Form 8-K - Current report:
SEC Accession No. 0001193125-25-112057
Filing Date
2025-05-05
Accepted
2025-05-05 07:15:22
Documents
16
Period of Report
2025-05-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d949868d8k.htm   iXBRL 8-K 24882
2 EX-99.1 d949868dex991.htm EX-99.1 24907
6 GRAPHIC g949868g0505105549782.jpg GRAPHIC 3130
7 GRAPHIC g949868g05u02.jpg GRAPHIC 178335
  Complete submission text file 0001193125-25-112057.txt   428844

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20250505.xsd EX-101.SCH 2861
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20250505_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20250505_pre.xml EX-101.PRE 10819
18 EXTRACTED XBRL INSTANCE DOCUMENT d949868d8k_htm.xml XML 3501
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 25910879
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)